The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
We propose a model selection criterion for correlated survival data when the cluster size is informative to the outcome. This approach, called Resampling Cluster Survival Information Criterion (RCSIC), uses the Cox proportional hazards model that is weighted with the inverse of the cluster size. The RCSIC based on the within‐cluster resampling idea takes into account the possible variability of the...
Phase 2 and 3 development failure is one of the key factors for high drug development cost. Robust prediction of a candidate drug's efficacy and safety profile could potentially improve the success rate of the drug development. Therefore, systematic evaluation of the prediction is important for learning and continuous improvement of the prediction. In this article, we proposed a set of unified criteria...